Ann: Phase IIb Canine Trial Identifies Therapeutic Window for MPL, page-68

First 68 Last

Share
Profile

Follow
UKTrader54

172 Posts.

90

01/05/21

15:19

Post #: 52868483
Share
Originally posted by Peeteepoo: ↑

HiAll,
Who'sin for a bit of Saturday morning speculation ?

We know 2 companies have already expressed an interest in the Canine Cancer application of MPL. 1 German and 1 in the US. 2 big Pharma companies in Germany are, Bayer and Boehringer Ingelheim. Bayer sold off their Vet arm to Elanco so that leaves Boehringer Ingelheim. Lets go with them as they are still big in Vet medicine.

Dr Kim Agnew
Elanco Associate Director Australia and New Zealand Research and Development to July 2015. So he may of been aware of MPL for some time and involved the Elanco's original decision to support PAA.

More recently he was.
Boehringer Ingelheim Research and Development Team Leader January 2017 - November 2020. When did RA first approach him to drive the Commercialization of MPL in Canines ?? Was he the person or one of them who was keen to get involved at Elanco and was surprised they didn't take up the offer ?

At first I thought that RA's comment about a single company taking the licenses was only for Human applications but after re-watching the video for the 3rd time. [Yep I know that's sad but I'm retired and its been raining] I am not so sure, he seamlessly and confidently went from talking about canines to making that statement.

So is it possible our German friends will come on board with the canines and are they keen to follow up with the human applications as well ? It would seem to make good business sense I think.

Bucky. Yes it is all speculation and just a bit of fun, so please join in and give your view it is always welcome.

Pete

Expand

Interesting theory @Peeteepoo

Zoetis is the biggest animal healthcare company in the world followed by the newly merged Elanco & Bayer. Then closely behind in 3rd spot is Boehringer Ingelheim who are located in Ingelheim just outside of Frankfurt, Germany.

PAA is also listed on Frankfurt Stock Exchange.
PAA Price at posting: 10.5¢ Sentiment: Hold Disclosure: Held
13 Upvote

Reply

Top Stories

Palladium's the newest geopolitical hot commodity. But ASX exposure is limited

Making money: How many microcaps should be in an investor's portfolio?

The Altcoin Landscape (Part 1): Key alternative cryptocurrencies to watch

Bitcoin hits fresh record as instos pile into BTC ETFs – and Trump helps, too

Aussie inflation seemingly hit a 3 year low. So why's the ASX200 red?